(Q45392719)

14 December 2017

title

Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells (English)

1 reference

14 December 2017

6

1 reference

14 December 2017

Adelheid Wöhrer

2

0 references

Andreas von Deimling

8

object named as

Andreas von Deimling

1 reference

14 December 2017

9

David Capper

1 reference

14 December 2017

4

Jens Schittenhelm

1 reference

14 December 2017

Christian Koelsche

1

1 reference

14 December 2017

Astrid Jeibmann

3

1 reference

14 December 2017

Genevieve Schindler

5

1 reference

14 December 2017

Felix Lasitschka

7

1 reference

14 December 2017

publication date

24 February 2013

1 reference

14 December 2017

published in

Acta Neuropathologica

1 reference

14 December 2017

volume

125

1 reference

14 December 2017

issue

6

1 reference

14 December 2017

page(s)

891-900

1 reference

https://scigraph.springernature.com/pub.10.1007/s00401-013-1100-2

14 December 2017

exact match

0 references

cites work

Immunogenicity of constitutively active V599EBRaf

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Mutational analysis of TSC1 and TSC2 genes in gangliogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Clinical and molecular characteristics of malignant transformation of low-grade glioma in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Malignant ganglioglioma: case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Unlocking the code of 14-3-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Comprehensive characterization of genomic aberrations in gangliogliomas by CGH, array-based CGH and interphase FISH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Profiling critical cancer gene mutations in clinical tumor samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

Pediatric primary anaplastic ganglioglioma: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1100-2

10.1007/S00401-013-1100-2

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

14 December 2017

1005778684

0 references

1 reference